Company Analysis

argenx SE (ARGX)

Nasdaq: ARGX · Biological Products, (No Diagnostic Substances) · filing with the SEC since 2017
Grade6.3
◀ Past 5.5● Present 6.3▶ Future 7.1
2 est.

Who runs argenx SE

The record holds no Form 3, 4 or 5 for this company yet, so no officer or director is named.
SI Assistanton ARGX · research, not advice